Lightnews — Scholar-powered news

Reposted by Maryam Lustberg MD MPH FASCO

Yale Cancer Center

@yalecancer.bsky.social

Ismail Ajjawi @yaleschoolofmed.bsky.social ’27 presents data on premenopausal women with early-stage HR+/HER2– node-negative #breastcancer at #SABCS25
• Chemo use ⬇️ 35%→24%
• 72% omitted chemo, w/no difference in 5-yr OS
@oncoalert.bsky.social @sabcs.bsky.social @maryamlustberg.bsky.social

December 12, 2025 at 1:43 AM

Reposted by Maryam Lustberg MD MPH FASCO

Yale Cancer Center

@yalecancer.bsky.social

Drs. Jessica Liu and Guannan Gong present new data #SABCS25 showing automated #ClinicalTrial Patient Matching (CTPM) helps identify diverse trial candidates, but additional strategies are needed to boost participation. @maryamlustberg.bsky.social

December 12, 2025 at 1:53 AM

Reposted by Maryam Lustberg MD MPH FASCO

Yale Cancer Center

@yalecancer.bsky.social

@maryamlustberg.bsky.social presents #REPOWER at #SABCS25 —an intl study of pts with stage II/III HR+/HER2- early #breastcancer receiving adjuvant ribociclib + endocrine therapy.
@oncoalert.bsky.social @sabcs.bsky.social

December 11, 2025 at 8:13 PM

Reposted by Maryam Lustberg MD MPH FASCO

Nicole Casasanta, MD

@ncasasanta.bsky.social

📌Starting #SABCS25 off with a discussion of the Advanced Breast Cancer (ABC) Global Decade Report 📈
🔸improved 5 year OS 26% ➡️33%
🔸improvement in QOL, but 79% report negative QOL
🔸access to care gaps have widened
✅ 10 goals 2025-2035
#bcsm @maryamlustberg.bsky.social

December 9, 2025 at 4:39 PM

Reposted by Maryam Lustberg MD MPH FASCO

Yale Cancer Center

@yalecancer.bsky.social

This afternoon at 2:30pm CST/3:30pm EST #SABCS25, @maryamlustberg.bsky.social shares two presentations during Education Session 4: Hormone Replacement Therapy in #BreastCancer Care.
sabcs.org/events/educa...
@sabcs.bsky.social

December 9, 2025 at 7:15 PM

Reposted by Maryam Lustberg MD MPH FASCO

Yale Cancer Center

@yalecancer.bsky.social

@maryamlustberg.bsky.social highlights the major unmet needs in #menopause care after #breastcancer at #SABCS25.
“Our patients have a lot of symptoms and they are not always being addressed — we need to do a lot better.” @sabcs.bsky.social

December 9, 2025 at 9:45 PM

Reposted by Maryam Lustberg MD MPH FASCO

Yale Cancer Center

@yalecancer.bsky.social

Important conversation at #SABCS25 on hormone replacement therapy in breast cancer care with Drs.
@lisalarkinmd.bsky.social, Jewel King, Thelma Brown,
@maryamlustberg.bsky.social, and Tara Sanft.
@theaacr.bsky.social @sabcs.bsky.social

December 10, 2025 at 1:41 PM

Reposted by Maryam Lustberg MD MPH FASCO

Yale Cancer Center

@yalecancer.bsky.social

@maryamlustberg.bsky.social breaks down key insights on hormone replacement therapy #HRT for #breastcancer survivors at #SABCS25: "We are not the hormone police—our role is to empower patients."
@sabcs.bsky.social

December 10, 2025 at 1:42 PM

Reposted by Maryam Lustberg MD MPH FASCO

Yale Cancer Center

@yalecancer.bsky.social

@maryamlustberg.bsky.social highlights why patient-reported outcomes (PROs) must be central to oncology drug development and clinical trials at #SABCS25: "Partnering with our patients and patient advocacy organizations is the path forward." @sabcs.bsky.social

December 10, 2025 at 9:20 PM

Reposted by Maryam Lustberg MD MPH FASCO

OncoDaily

@oncodaily.bsky.social

15 Posts Not to Miss from SABCS 2025, Part 1

@sabcs.bsky.social @drsgraff.bsky.social @ptarantinomd.bsky.social @stage4kelly.bsky.social @maryamlustberg.bsky.social

oncodaily.com/not-to-miss/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #SABCS #SABCS25 #SABCS2025

15 Posts Not to Miss from SABCS 2025, Part 1 - OncoDaily

15 Posts Not to Miss from SABCS 2025, Part 1 / Adrian Lee, Amol Akhade, cancer, Elisabetta Bonzano MD, Erica Mayer, Headlines, Hope Rugo, Jason A. Mouabbi,

oncodaily.com

December 10, 2025 at 10:18 PM

Reposted by Maryam Lustberg MD MPH FASCO

Yale Cancer Center

@yalecancer.bsky.social

Dr. Guannan Gong shares how an #AI-driven patient-matching system improved ID of eligible patients for #breastcancer trials + increased representation of under-enrolled groups. #SABCS25
@maryamlustberg.bsky.social
@sabcs.bsky.social
@oncoalert.bsky.social

December 11, 2025 at 1:17 PM

Reposted by Maryam Lustberg MD MPH FASCO

Yale Cancer Center

@yalecancer.bsky.social

Powerful message from Dr. Amy Beumer at #SABCS25: It’s time to “fix the toxic friendship” and design dosing with patients—balancing side effects, quality of life, and longevity. @maryamlustberg.bsky.social @sabcs.bsky.social

December 10, 2025 at 11:48 PM

Reposted by Maryam Lustberg MD MPH FASCO

San Antonio Breast Cancer Symposium

@sabcs.bsky.social

Balancing Act: Hormone Replacement Therapy in Breast Cancer Care—
Maryam Lustberg, Juliana Kling, Lisa Larkin, & advocate Thelma P. Brown addressed this topic in an #SABCS25 educational session moderated by Tana Sanft.
@maryamlustberg.bsky.social @lisalarkinmd.bsky.social @drjewelk.bsky.social

December 9, 2025 at 9:56 PM

Reposted by Maryam Lustberg MD MPH FASCO

Yale Cancer Center

@yalecancer.bsky.social

The editors of @ascocancer.bsky.social's #JCOOncologyAdvances recently met at the ASCO HQ to discuss strategy and planning for the year ahead.
@pamelakunzmd.bsky.social serves as editor-in-chief and she
was joined by associate editors, including Yale’s
@maryamlustberg.bsky.social.

October 9, 2025 at 4:22 PM

Reposted by Maryam Lustberg MD MPH FASCO

Yale Cancer Center

@yalecancer.bsky.social

@maryamlustberg.bsky.social shares insights on #breastcancer prevention, treatment, and new research, in honor of #breastcancerawarenessmonth tonight at 7:30pm on #YaleCancerAnswers.
🎧Listen live on WNPR
🔁Download on Apple Podcasts
💻Watch on YouTube

October 19, 2025 at 8:49 PM

Reposted by Maryam Lustberg MD MPH FASCO

Yale Cancer Center

@yalecancer.bsky.social

Thank you to everyone that joined us Wednesday night at the
#SaybrookResortandMarina for an evening of networking and
connections around the topic of #womenshealth!
@maryamlustberg.bsky.social

October 24, 2025 at 3:17 PM

Reposted by Maryam Lustberg MD MPH FASCO

MASCC

@cancercaremascc.bsky.social

We’re hosting a webinar for members on “Centering Voices: Best Practices for Engaging People with Lived Experience in Supportive Care in Cancer”.

Registration is open to all members. To become a member, click here: mascc.org/join-mascc/

#SuppOnc @maryamlustberg.bsky.social @coffeemommy.bsky.social

November 10, 2025 at 4:17 PM

Reposted by Maryam Lustberg MD MPH FASCO

OncoDaily

@oncodaily.bsky.social

ABC Global Alliance - Maryam Lustberg on Supportive and Oncological Care at ABC8

@maryamlustberg.bsky.social

oncodaily.com/voices/marya...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

Maryam Lustberg on Supportive and Oncological Care at ABC8 - ABC Global Alliance - OncoDaily

Maryam Lustberg on Supportive and Oncological Care at ABC8 - ABC Global Alliance / ABC Global Alliance meeting, ABC8, Breast Cancer, cancer, Maryam Lustberg,

oncodaily.com

November 11, 2025 at 12:20 AM

Reposted by Maryam Lustberg MD MPH FASCO

Yale Cancer Center

@yalecancer.bsky.social

An empowering + emotional day at our Caring for Metastatic Breast Cancer conference on Saturday. 💗 From groundbreaking research to personal stories of strength, we're reminded: no one faces #MBC alone.
#BreastFriendsFund
@maryamlustberg.bsky.social

October 6, 2025 at 12:14 PM

Reposted by Maryam Lustberg MD MPH FASCO

Yale Cancer Center

@yalecancer.bsky.social

In metastatic #breastcancer, sacituzumab govitecan given after trastuzumab deruxtecan was linked to ⬇️ PFS across all subtypes. Real-world data published in #JNCI show differences in outcomes by type. academic.oup.com/jnci/advance...
@maryamlustberg.bsky.social

Outcomes of subsequent treatment regimens after trastuzumab deruxtecan in patients with metastatic breast cancer

AbstractBackground. Most patients with metastatic breast cancer (MBC) are eligible for treatment with trastuzumab deruxtecan (T-DXd). No data are available

academic.oup.com

August 19, 2025 at 11:56 AM

Reposted by Maryam Lustberg MD MPH FASCO

MASCC

@cancercaremascc.bsky.social

A big thank you once again to our dedicated Social Media Ambassadors for 2025:

@maryamlustberg.bsky.social @darcyburbage.bsky.social
@coffeemommy.bsky.social @bogda-koczwara.bsky.social
@stage4kelly.bsky.social

Thank you for your insightful posting across the three days of #MASCC25!

June 28, 2025 at 10:35 PM

Maryam Lustberg MD MPH FASCO

@maryamlustberg.bsky.social

Thank you!

June 28, 2025 at 6:58 AM

Reposted by Maryam Lustberg MD MPH FASCO

Yale Cancer Center

@yalecancer.bsky.social

Congratulations to @maryamlustberg.bsky.social named an inaugural @cancercaremascc.bsky.social Fellow during #mascc25!

MASCC @cancercaremascc.bsky.social · Jun 26

In 2025, we welcome and congratulate our inaugural cohort of MASCC Fellows (FMASCC). Fellow status is awarded to individuals who have made a sustained contribution to MASCC and demonstrated a continued high level of excellence in cancer supportive care practice and/or research.

#MASCC25